[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Extracorporeal Lithotripter, Market Insights and Forecast to 2026

September 2020 | 145 pages | ID: CFCE80A9E4D0EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Extracorporeal Lithotripter market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Extracorporeal Lithotripter market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Extracorporeal Lithotripter market is segmented into
  • Table-top/Portable Device
  • Hand-push Type Device
Segment by Application, the Extracorporeal Lithotripter market is segmented into
  • Medical Institutions
  • Physical Therapy and Sports Center
Regional and Country-level Analysis
The Extracorporeal Lithotripter market is analysed and market size information is provided by regions (countries).

The key regions covered in the Extracorporeal Lithotripter market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Extracorporeal Lithotripter Market Share Analysis
Extracorporeal Lithotripter market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Extracorporeal Lithotripter by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Extracorporeal Lithotripter business, the date to enter into the Extracorporeal Lithotripter market, Extracorporeal Lithotripter product introduction, recent developments, etc.

The major vendors covered:
  • Chattanooga(DJO)(US)
  • BTL(UK)
  • Storz Medical(Switzerland)
  • EMS Electro Medical Systems(Switzerland)
  • MTS Medical(Germany)
  • Zimmer MedizinSysteme(Germany)
  • Gymna(Belgium)
  • Likamed GmbH(Germany)
  • Inceler Medikal(Turkey)
  • HANIL-TM(Korea)
  • HnT Medical(Korea)
  • Urontech(Korea)
  • Wikkon(China)
  • Longest(China)
  • Xiangyu Medical(China)
1 STUDY COVERAGE

1.1 Extracorporeal Lithotripter Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Extracorporeal Lithotripter Manufacturers by Revenue in 2019
1.4 Market by Type
  1.4.1 Global Extracorporeal Lithotripter Market Size Growth Rate by Type
  1.4.2 Table-top/Portable Device
  1.4.3 Hand-push Type Device
1.5 Market by Application
  1.5.1 Global Extracorporeal Lithotripter Market Size Growth Rate by Application
  1.5.2 Medical Institutions
  1.5.3 Physical Therapy and Sports Center
1.6 Coronavirus Disease 2019 (Covid-19): Extracorporeal Lithotripter Industry Impact
  1.6.1 How the Covid-19 is Affecting the Extracorporeal Lithotripter Industry
    1.6.1.1 Extracorporeal Lithotripter Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Extracorporeal Lithotripter Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Extracorporeal Lithotripter Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Extracorporeal Lithotripter Market Size Estimates and Forecasts
  2.1.1 Global Extracorporeal Lithotripter Revenue Estimates and Forecasts 2015-2026
  2.1.2 Global Extracorporeal Lithotripter Production Capacity Estimates and Forecasts 2015-2026
  2.1.3 Global Extracorporeal Lithotripter Production Estimates and Forecasts 2015-2026
2.2 Global Extracorporeal Lithotripter Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
  2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  2.3.2 Global Extracorporeal Lithotripter Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  2.3.3 Global Extracorporeal Lithotripter Manufacturers Geographical Distribution
2.4 Key Trends for Extracorporeal Lithotripter Markets & Products
2.5 Primary Interviews with Key Extracorporeal Lithotripter Players (Opinion Leaders)

3 MARKET SIZE BY MANUFACTURERS

3.1 Global Top Extracorporeal Lithotripter Manufacturers by Production Capacity
  3.1.1 Global Top Extracorporeal Lithotripter Manufacturers by Production Capacity (2015-2020)
  3.1.2 Global Top Extracorporeal Lithotripter Manufacturers by Production (2015-2020)
  3.1.3 Global Top Extracorporeal Lithotripter Manufacturers Market Share by Production
3.2 Global Top Extracorporeal Lithotripter Manufacturers by Revenue
  3.2.1 Global Top Extracorporeal Lithotripter Manufacturers by Revenue (2015-2020)
  3.2.2 Global Top Extracorporeal Lithotripter Manufacturers Market Share by Revenue (2015-2020)
  3.2.3 Global Top 10 and Top 5 Companies by Extracorporeal Lithotripter Revenue in 2019
3.3 Global Extracorporeal Lithotripter Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 EXTRACORPOREAL LITHOTRIPTER PRODUCTION BY REGIONS

4.1 Global Extracorporeal Lithotripter Historic Market Facts & Figures by Regions
  4.1.1 Global Top Extracorporeal Lithotripter Regions by Production (2015-2020)
  4.1.2 Global Top Extracorporeal Lithotripter Regions by Revenue (2015-2020)
4.2 North America
  4.2.1 North America Extracorporeal Lithotripter Production (2015-2020)
  4.2.2 North America Extracorporeal Lithotripter Revenue (2015-2020)
  4.2.3 Key Players in North America
  4.2.4 North America Extracorporeal Lithotripter Import & Export (2015-2020)
4.3 Europe
  4.3.1 Europe Extracorporeal Lithotripter Production (2015-2020)
  4.3.2 Europe Extracorporeal Lithotripter Revenue (2015-2020)
  4.3.3 Key Players in Europe
  4.3.4 Europe Extracorporeal Lithotripter Import & Export (2015-2020)
4.4 China
  4.4.1 China Extracorporeal Lithotripter Production (2015-2020)
  4.4.2 China Extracorporeal Lithotripter Revenue (2015-2020)
  4.4.3 Key Players in China
  4.4.4 China Extracorporeal Lithotripter Import & Export (2015-2020)
4.5 Japan
  4.5.1 Japan Extracorporeal Lithotripter Production (2015-2020)
  4.5.2 Japan Extracorporeal Lithotripter Revenue (2015-2020)
  4.5.3 Key Players in Japan
  4.5.4 Japan Extracorporeal Lithotripter Import & Export (2015-2020)

5 EXTRACORPOREAL LITHOTRIPTER CONSUMPTION BY REGION

5.1 Global Top Extracorporeal Lithotripter Regions by Consumption
  5.1.1 Global Top Extracorporeal Lithotripter Regions by Consumption (2015-2020)
  5.1.2 Global Top Extracorporeal Lithotripter Regions Market Share by Consumption (2015-2020)
5.2 North America
  5.2.1 North America Extracorporeal Lithotripter Consumption by Application
  5.2.2 North America Extracorporeal Lithotripter Consumption by Countries
  5.2.3 U.S.
  5.2.4 Canada
5.3 Europe
  5.3.1 Europe Extracorporeal Lithotripter Consumption by Application
  5.3.2 Europe Extracorporeal Lithotripter Consumption by Countries
  5.3.3 Germany
  5.3.4 France
  5.3.5 U.K.
  5.3.6 Italy
  5.3.7 Russia
5.4 Asia Pacific
  5.4.1 Asia Pacific Extracorporeal Lithotripter Consumption by Application
  5.4.2 Asia Pacific Extracorporeal Lithotripter Consumption by Regions
  5.4.3 China
  5.4.4 Japan
  5.4.5 South Korea
  5.4.6 India
  5.4.7 Australia
  5.4.8 Taiwan
  5.4.9 Indonesia
  5.4.10 Thailand
  5.4.11 Malaysia
  5.4.12 Philippines
  5.4.13 Vietnam
5.5 Central & South America
  5.5.1 Central & South America Extracorporeal Lithotripter Consumption by Application
  5.5.2 Central & South America Extracorporeal Lithotripter Consumption by Country
  5.5.3 Mexico
  5.5.3 Brazil
  5.5.3 Argentina
5.6 Middle East and Africa
  5.6.1 Middle East and Africa Extracorporeal Lithotripter Consumption by Application
  5.6.2 Middle East and Africa Extracorporeal Lithotripter Consumption by Countries
  5.6.3 Turkey
  5.6.4 Saudi Arabia
  5.6.5 U.A.E

6 MARKET SIZE BY TYPE (2015-2026)

6.1 Global Extracorporeal Lithotripter Market Size by Type (2015-2020)
  6.1.1 Global Extracorporeal Lithotripter Production by Type (2015-2020)
  6.1.2 Global Extracorporeal Lithotripter Revenue by Type (2015-2020)
  6.1.3 Extracorporeal Lithotripter Price by Type (2015-2020)
6.2 Global Extracorporeal Lithotripter Market Forecast by Type (2021-2026)
  6.2.1 Global Extracorporeal Lithotripter Production Forecast by Type (2021-2026)
  6.2.2 Global Extracorporeal Lithotripter Revenue Forecast by Type (2021-2026)
  6.2.3 Global Extracorporeal Lithotripter Price Forecast by Type (2021-2026)
6.3 Global Extracorporeal Lithotripter Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 MARKET SIZE BY APPLICATION (2015-2026)

  7.2.1 Global Extracorporeal Lithotripter Consumption Historic Breakdown by Application (2015-2020)
  7.2.2 Global Extracorporeal Lithotripter Consumption Forecast by Application (2021-2026)

8 CORPORATE PROFILES

8.1 Chattanooga(DJO)(US)
  8.1.1 Chattanooga(DJO)(US) Corporation Information
  8.1.2 Chattanooga(DJO)(US) Overview and Its Total Revenue
  8.1.3 Chattanooga(DJO)(US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.1.4 Chattanooga(DJO)(US) Product Description
  8.1.5 Chattanooga(DJO)(US) Recent Development
8.2 BTL(UK)
  8.2.1 BTL(UK) Corporation Information
  8.2.2 BTL(UK) Overview and Its Total Revenue
  8.2.3 BTL(UK) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.2.4 BTL(UK) Product Description
  8.2.5 BTL(UK) Recent Development
8.3 Storz Medical(Switzerland)
  8.3.1 Storz Medical(Switzerland) Corporation Information
  8.3.2 Storz Medical(Switzerland) Overview and Its Total Revenue
  8.3.3 Storz Medical(Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.3.4 Storz Medical(Switzerland) Product Description
  8.3.5 Storz Medical(Switzerland) Recent Development
8.4 EMS Electro Medical Systems(Switzerland)
  8.4.1 EMS Electro Medical Systems(Switzerland) Corporation Information
  8.4.2 EMS Electro Medical Systems(Switzerland) Overview and Its Total Revenue
  8.4.3 EMS Electro Medical Systems(Switzerland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.4.4 EMS Electro Medical Systems(Switzerland) Product Description
  8.4.5 EMS Electro Medical Systems(Switzerland) Recent Development
8.5 MTS Medical(Germany)
  8.5.1 MTS Medical(Germany) Corporation Information
  8.5.2 MTS Medical(Germany) Overview and Its Total Revenue
  8.5.3 MTS Medical(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.5.4 MTS Medical(Germany) Product Description
  8.5.5 MTS Medical(Germany) Recent Development
8.6 Zimmer MedizinSysteme(Germany)
  8.6.1 Zimmer MedizinSysteme(Germany) Corporation Information
  8.6.2 Zimmer MedizinSysteme(Germany) Overview and Its Total Revenue
  8.6.3 Zimmer MedizinSysteme(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.6.4 Zimmer MedizinSysteme(Germany) Product Description
  8.6.5 Zimmer MedizinSysteme(Germany) Recent Development
8.7 Gymna(Belgium)
  8.7.1 Gymna(Belgium) Corporation Information
  8.7.2 Gymna(Belgium) Overview and Its Total Revenue
  8.7.3 Gymna(Belgium) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.7.4 Gymna(Belgium) Product Description
  8.7.5 Gymna(Belgium) Recent Development
8.8 Likamed GmbH(Germany)
  8.8.1 Likamed GmbH(Germany) Corporation Information
  8.8.2 Likamed GmbH(Germany) Overview and Its Total Revenue
  8.8.3 Likamed GmbH(Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.8.4 Likamed GmbH(Germany) Product Description
  8.8.5 Likamed GmbH(Germany) Recent Development
8.9 Inceler Medikal(Turkey)
  8.9.1 Inceler Medikal(Turkey) Corporation Information
  8.9.2 Inceler Medikal(Turkey) Overview and Its Total Revenue
  8.9.3 Inceler Medikal(Turkey) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.9.4 Inceler Medikal(Turkey) Product Description
  8.9.5 Inceler Medikal(Turkey) Recent Development
8.10 HANIL-TM(Korea)
  8.10.1 HANIL-TM(Korea) Corporation Information
  8.10.2 HANIL-TM(Korea) Overview and Its Total Revenue
  8.10.3 HANIL-TM(Korea) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.10.4 HANIL-TM(Korea) Product Description
  8.10.5 HANIL-TM(Korea) Recent Development
8.11 HnT Medical(Korea)
  8.11.1 HnT Medical(Korea) Corporation Information
  8.11.2 HnT Medical(Korea) Overview and Its Total Revenue
  8.11.3 HnT Medical(Korea) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.11.4 HnT Medical(Korea) Product Description
  8.11.5 HnT Medical(Korea) Recent Development
8.12 Urontech(Korea)
  8.12.1 Urontech(Korea) Corporation Information
  8.12.2 Urontech(Korea) Overview and Its Total Revenue
  8.12.3 Urontech(Korea) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.12.4 Urontech(Korea) Product Description
  8.12.5 Urontech(Korea) Recent Development
8.13 Wikkon(China)
  8.13.1 Wikkon(China) Corporation Information
  8.13.2 Wikkon(China) Overview and Its Total Revenue
  8.13.3 Wikkon(China) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.13.4 Wikkon(China) Product Description
  8.13.5 Wikkon(China) Recent Development
8.14 Longest(China)
  8.14.1 Longest(China) Corporation Information
  8.14.2 Longest(China) Overview and Its Total Revenue
  8.14.3 Longest(China) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.14.4 Longest(China) Product Description
  8.14.5 Longest(China) Recent Development
8.15 Xiangyu Medical(China)
  8.15.1 Xiangyu Medical(China) Corporation Information
  8.15.2 Xiangyu Medical(China) Overview and Its Total Revenue
  8.15.3 Xiangyu Medical(China) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.15.4 Xiangyu Medical(China) Product Description
  8.15.5 Xiangyu Medical(China) Recent Development
8.16 Shengchang Medical(China)
  8.16.1 Shengchang Medical(China) Corporation Information
  8.16.2 Shengchang Medical(China) Overview and Its Total Revenue
  8.16.3 Shengchang Medical(China) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  8.16.4 Shengchang Medical(China) Product Description
  8.16.5 Shengchang Medical(China) Recent Development

9 PRODUCTION FORECASTS BY REGIONS

9.1 Global Top Extracorporeal Lithotripter Regions Forecast by Revenue (2021-2026)
9.2 Global Top Extracorporeal Lithotripter Regions Forecast by Production (2021-2026)
9.3 Key Extracorporeal Lithotripter Production Regions Forecast
  9.3.1 North America
  9.3.2 Europe
  9.3.3 China
  9.3.4 Japan

10 EXTRACORPOREAL LITHOTRIPTER CONSUMPTION FORECAST BY REGION

10.1 Global Extracorporeal Lithotripter Consumption Forecast by Region (2021-2026)
10.2 North America Extracorporeal Lithotripter Consumption Forecast by Region (2021-2026)
10.3 Europe Extracorporeal Lithotripter Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Extracorporeal Lithotripter Consumption Forecast by Region (2021-2026)
10.5 Latin America Extracorporeal Lithotripter Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Extracorporeal Lithotripter Consumption Forecast by Region (2021-2026)

11 VALUE CHAIN AND SALES CHANNELS ANALYSIS

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
  11.2.1 Extracorporeal Lithotripter Sales Channels
  11.2.2 Extracorporeal Lithotripter Distributors
11.3 Extracorporeal Lithotripter Customers

12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis

13 KEY FINDING IN THE GLOBAL EXTRACORPOREAL LITHOTRIPTER STUDY

14 APPENDIX

14.1 Research Methodology
  14.1.1 Methodology/Research Approach
  14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

LIST OF TABLES

Table 1. Extracorporeal Lithotripter Key Market Segments in This Study
Table 2. Ranking of Global Top Extracorporeal Lithotripter Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Extracorporeal Lithotripter Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Table-top/Portable Device
Table 5. Major Manufacturers of Hand-push Type Device
Table 6. COVID-19 Impact Global Market: (Four Extracorporeal Lithotripter Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Extracorporeal Lithotripter Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Extracorporeal Lithotripter Players to Combat Covid-19 Impact
Table 11. Global Extracorporeal Lithotripter Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Extracorporeal Lithotripter Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Extracorporeal Lithotripter by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extracorporeal Lithotripter as of 2019)
Table 15. Extracorporeal Lithotripter Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Extracorporeal Lithotripter Product Offered
Table 17. Date of Manufacturers Enter into Extracorporeal Lithotripter Market
Table 18. Key Trends for Extracorporeal Lithotripter Markets & Products
Table 19. Main Points Interviewed from Key Extracorporeal Lithotripter Players
Table 20. Global Extracorporeal Lithotripter Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Extracorporeal Lithotripter Production Share by Manufacturers (2015-2020)
Table 22. Extracorporeal Lithotripter Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Extracorporeal Lithotripter Revenue Share by Manufacturers (2015-2020)
Table 24. Extracorporeal Lithotripter Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Extracorporeal Lithotripter Production by Regions (2015-2020) (K Units)
Table 27. Global Extracorporeal Lithotripter Production Market Share by Regions (2015-2020)
Table 28. Global Extracorporeal Lithotripter Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Extracorporeal Lithotripter Revenue Market Share by Regions (2015-2020)
Table 30. Key Extracorporeal Lithotripter Players in North America
Table 31. Import & Export of Extracorporeal Lithotripter in North America (K Units)
Table 32. Key Extracorporeal Lithotripter Players in Europe
Table 33. Import & Export of Extracorporeal Lithotripter in Europe (K Units)
Table 34. Key Extracorporeal Lithotripter Players in China
Table 35. Import & Export of Extracorporeal Lithotripter in China (K Units)
Table 36. Key Extracorporeal Lithotripter Players in Japan
Table 37. Import & Export of Extracorporeal Lithotripter in Japan (K Units)
Table 38. Global Extracorporeal Lithotripter Consumption by Regions (2015-2020) (K Units)
Table 39. Global Extracorporeal Lithotripter Consumption Market Share by Regions (2015-2020)
Table 40. North America Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 41. North America Extracorporeal Lithotripter Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 43. Europe Extracorporeal Lithotripter Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Extracorporeal Lithotripter Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Extracorporeal Lithotripter Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Extracorporeal Lithotripter Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Extracorporeal Lithotripter Consumption by Countries (2015-2020) (K Units)
Table 51. Global Extracorporeal Lithotripter Production by Type (2015-2020) (K Units)
Table 52. Global Extracorporeal Lithotripter Production Share by Type (2015-2020)
Table 53. Global Extracorporeal Lithotripter Revenue by Type (2015-2020) (Million US$)
Table 54. Global Extracorporeal Lithotripter Revenue Share by Type (2015-2020)
Table 55. Extracorporeal Lithotripter Price by Type 2015-2020 (USD/Unit)
Table 56. Global Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 57. Global Extracorporeal Lithotripter Consumption by Application (2015-2020) (K Units)
Table 58. Global Extracorporeal Lithotripter Consumption Share by Application (2015-2020)
Table 59. Chattanooga(DJO)(US) Corporation Information
Table 60. Chattanooga(DJO)(US) Description and Major Businesses
Table 61. Chattanooga(DJO)(US) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Chattanooga(DJO)(US) Product
Table 63. Chattanooga(DJO)(US) Recent Development
Table 64. BTL(UK) Corporation Information
Table 65. BTL(UK) Description and Major Businesses
Table 66. BTL(UK) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. BTL(UK) Product
Table 68. BTL(UK) Recent Development
Table 69. Storz Medical(Switzerland) Corporation Information
Table 70. Storz Medical(Switzerland) Description and Major Businesses
Table 71. Storz Medical(Switzerland) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Storz Medical(Switzerland) Product
Table 73. Storz Medical(Switzerland) Recent Development
Table 74. EMS Electro Medical Systems(Switzerland) Corporation Information
Table 75. EMS Electro Medical Systems(Switzerland) Description and Major Businesses
Table 76. EMS Electro Medical Systems(Switzerland) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. EMS Electro Medical Systems(Switzerland) Product
Table 78. EMS Electro Medical Systems(Switzerland) Recent Development
Table 79. MTS Medical(Germany) Corporation Information
Table 80. MTS Medical(Germany) Description and Major Businesses
Table 81. MTS Medical(Germany) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. MTS Medical(Germany) Product
Table 83. MTS Medical(Germany) Recent Development
Table 84. Zimmer MedizinSysteme(Germany) Corporation Information
Table 85. Zimmer MedizinSysteme(Germany) Description and Major Businesses
Table 86. Zimmer MedizinSysteme(Germany) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Zimmer MedizinSysteme(Germany) Product
Table 88. Zimmer MedizinSysteme(Germany) Recent Development
Table 89. Gymna(Belgium) Corporation Information
Table 90. Gymna(Belgium) Description and Major Businesses
Table 91. Gymna(Belgium) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Gymna(Belgium) Product
Table 93. Gymna(Belgium) Recent Development
Table 94. Likamed GmbH(Germany) Corporation Information
Table 95. Likamed GmbH(Germany) Description and Major Businesses
Table 96. Likamed GmbH(Germany) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Likamed GmbH(Germany) Product
Table 98. Likamed GmbH(Germany) Recent Development
Table 99. Inceler Medikal(Turkey) Corporation Information
Table 100. Inceler Medikal(Turkey) Description and Major Businesses
Table 101. Inceler Medikal(Turkey) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Inceler Medikal(Turkey) Product
Table 103. Inceler Medikal(Turkey) Recent Development
Table 104. HANIL-TM(Korea) Corporation Information
Table 105. HANIL-TM(Korea) Description and Major Businesses
Table 106. HANIL-TM(Korea) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. HANIL-TM(Korea) Product
Table 108. HANIL-TM(Korea) Recent Development
Table 109. HnT Medical(Korea) Corporation Information
Table 110. HnT Medical(Korea) Description and Major Businesses
Table 111. HnT Medical(Korea) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. HnT Medical(Korea) Product
Table 113. HnT Medical(Korea) Recent Development
Table 114. Urontech(Korea) Corporation Information
Table 115. Urontech(Korea) Description and Major Businesses
Table 116. Urontech(Korea) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Urontech(Korea) Product
Table 118. Urontech(Korea) Recent Development
Table 119. Wikkon(China) Corporation Information
Table 120. Wikkon(China) Description and Major Businesses
Table 121. Wikkon(China) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Wikkon(China) Product
Table 123. Wikkon(China) Recent Development
Table 124. Longest(China) Corporation Information
Table 125. Longest(China) Description and Major Businesses
Table 126. Longest(China) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Longest(China) Product
Table 128. Longest(China) Recent Development
Table 129. Xiangyu Medical(China) Corporation Information
Table 130. Xiangyu Medical(China) Description and Major Businesses
Table 131. Xiangyu Medical(China) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Xiangyu Medical(China) Product
Table 133. Xiangyu Medical(China) Recent Development
Table 134. Shengchang Medical(China) Corporation Information
Table 135. Shengchang Medical(China) Description and Major Businesses
Table 136. Shengchang Medical(China) Extracorporeal Lithotripter Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Shengchang Medical(China) Product
Table 138. Shengchang Medical(China) Recent Development
Table 139. Global Extracorporeal Lithotripter Revenue Forecast by Region (2021-2026) (Million US$)
Table 140. Global Extracorporeal Lithotripter Production Forecast by Regions (2021-2026) (K Units)
Table 141. Global Extracorporeal Lithotripter Production Forecast by Type (2021-2026) (K Units)
Table 142. Global Extracorporeal Lithotripter Revenue Forecast by Type (2021-2026) (Million US$)
Table 143. North America Extracorporeal Lithotripter Consumption Forecast by Regions (2021-2026) (K Units)
Table 144. Europe Extracorporeal Lithotripter Consumption Forecast by Regions (2021-2026) (K Units)
Table 145. Asia Pacific Extracorporeal Lithotripter Consumption Forecast by Regions (2021-2026) (K Units)
Table 146. Latin America Extracorporeal Lithotripter Consumption Forecast by Regions (2021-2026) (K Units)
Table 147. Middle East and Africa Extracorporeal Lithotripter Consumption Forecast by Regions (2021-2026) (K Units)
Table 148. Extracorporeal Lithotripter Distributors List
Table 149. Extracorporeal Lithotripter Customers List
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Extracorporeal Lithotripter Product Picture
Figure 2. Global Extracorporeal Lithotripter Production Market Share by Type in 2020 & 2026
Figure 3. Table-top/Portable Device Product Picture
Figure 4. Hand-push Type Device Product Picture
Figure 5. Global Extracorporeal Lithotripter Consumption Market Share by Application in 2020 & 2026
Figure 6. Medical Institutions
Figure 7. Physical Therapy and Sports Center
Figure 8. Extracorporeal Lithotripter Report Years Considered
Figure 9. Global Extracorporeal Lithotripter Revenue 2015-2026 (Million US$)
Figure 10. Global Extracorporeal Lithotripter Production Capacity 2015-2026 (K Units)
Figure 11. Global Extracorporeal Lithotripter Production 2015-2026 (K Units)
Figure 12. Global Extracorporeal Lithotripter Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 13. Extracorporeal Lithotripter Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 14. Global Extracorporeal Lithotripter Production Share by Manufacturers in 2015
Figure 15. The Top 10 and Top 5 Players Market Share by Extracorporeal Lithotripter Revenue in 2019
Figure 16. Global Extracorporeal Lithotripter Production Market Share by Region (2015-2020)
Figure 17. Extracorporeal Lithotripter Production Growth Rate in North America (2015-2020) (K Units)
Figure 18. Extracorporeal Lithotripter Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 19. Extracorporeal Lithotripter Production Growth Rate in Europe (2015-2020) (K Units)
Figure 20. Extracorporeal Lithotripter Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 21. Extracorporeal Lithotripter Production Growth Rate in China (2015-2020) (K Units)
Figure 22. Extracorporeal Lithotripter Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 23. Extracorporeal Lithotripter Production Growth Rate in Japan (2015-2020) (K Units)
Figure 24. Extracorporeal Lithotripter Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 25. Global Extracorporeal Lithotripter Consumption Market Share by Regions 2015-2020
Figure 26. North America Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 27. North America Extracorporeal Lithotripter Consumption Market Share by Application in 2019
Figure 28. North America Extracorporeal Lithotripter Consumption Market Share by Countries in 2019
Figure 29. U.S. Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. Canada Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Europe Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Extracorporeal Lithotripter Consumption Market Share by Application in 2019
Figure 33. Europe Extracorporeal Lithotripter Consumption Market Share by Countries in 2019
Figure 34. Germany Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. France Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Italy Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Russia Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Asia Pacific Extracorporeal Lithotripter Consumption and Growth Rate (K Units)
Figure 40. Asia Pacific Extracorporeal Lithotripter Consumption Market Share by Application in 2019
Figure 41. Asia Pacific Extracorporeal Lithotripter Consumption Market Share by Regions in 2019
Figure 42. China Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Japan Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. India Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Australia Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Taiwan Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Indonesia Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Thailand Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Malaysia Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Philippines Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Vietnam Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Latin America Extracorporeal Lithotripter Consumption and Growth Rate (K Units)
Figure 54. Latin America Extracorporeal Lithotripter Consumption Market Share by Application in 2019
Figure 55. Latin America Extracorporeal Lithotripter Consumption Market Share by Countries in 2019
Figure 56. Mexico Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Brazil Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Argentina Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Middle East and Africa Extracorporeal Lithotripter Consumption and Growth Rate (K Units)
Figure 60. Middle East and Africa Extracorporeal Lithotripter Consumption Market Share by Application in 2019
Figure 61. Middle East and Africa Extracorporeal Lithotripter Consumption Market Share by Countries in 2019
Figure 62. Turkey Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Saudi Arabia Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. U.A.E Extracorporeal Lithotripter Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Global Extracorporeal Lithotripter Production Market Share by Type (2015-2020)
Figure 66. Global Extracorporeal Lithotripter Production Market Share by Type in 2019
Figure 67. Global Extracorporeal Lithotripter Revenue Market Share by Type (2015-2020)
Figure 68. Global Extracorporeal Lithotripter Revenue Market Share by Type in 2019
Figure 69. Global Extracorporeal Lithotripter Production Market Share Forecast by Type (2021-2026)
Figure 70. Global Extracorporeal Lithotripter Revenue Market Share Forecast by Type (2021-2026)
Figure 71. Global Extracorporeal Lithotripter Market Share by Price Range (2015-2020)
Figure 72. Global Extracorporeal Lithotripter Consumption Market Share by Application (2015-2020)
Figure 73. Global Extracorporeal Lithotripter Value (Consumption) Market Share by Application (2015-2020)
Figure 74. Global Extracorporeal Lithotripter Consumption Market Share Forecast by Application (2021-2026)
Figure 75. Chattanooga(DJO)(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. BTL(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Storz Medical(Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. EMS Electro Medical Systems(Switzerland) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. MTS Medical(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Zimmer MedizinSysteme(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Gymna(Belgium) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Likamed GmbH(Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Inceler Medikal(Turkey) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. HANIL-TM(Korea) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. HnT Medical(Korea) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Urontech(Korea) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Wikkon(China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Longest(China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Xiangyu Medical(China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Shengchang Medical(China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Global Extracorporeal Lithotripter Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 92. Global Extracorporeal Lithotripter Revenue Market Share Forecast by Regions ((2021-2026))
Figure 93. Global Extracorporeal Lithotripter Production Forecast by Regions (2021-2026) (K Units)
Figure 94. North America Extracorporeal Lithotripter Production Forecast (2021-2026) (K Units)
Figure 95. North America Extracorporeal Lithotripter Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Europe Extracorporeal Lithotripter Production Forecast (2021-2026) (K Units)
Figure 97. Europe Extracorporeal Lithotripter Revenue Forecast (2021-2026) (US$ Million)
Figure 98. China Extracorporeal Lithotripter Production Forecast (2021-2026) (K Units)
Figure 99. China Extracorporeal Lithotripter Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Japan Extracorporeal Lithotripter Production Forecast (2021-2026) (K Units)
Figure 101. Japan Extracorporeal Lithotripter Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Global Extracorporeal Lithotripter Consumption Market Share Forecast by Region (2021-2026)
Figure 103. Extracorporeal Lithotripter Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed


More Publications